Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2002

Satagopan Jaya M, Boyd Jeff, Kauff Noah D, Robson Mark, Scheuer Lauren, Narod Steven, Offit Kenneth

Abstract excerpt

PURPOSE: Several studies to date have reported ovarian cancer risk due to inherited BRCA1 and BRCA2 mutations using familial data or population-based series of probands. Familial aggregation associated with both of these methods may result in a substantial ascertainment bias. To address this, we have used a case-control design that does not involve familial aggregation to estimate the lifetime penetrance of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Incidence

Share to Odds Ratio

Share to Ovarian Neoplasms

Share to United States

Source

Identifiers

PMID: 12473589

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.PMID 12473589Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.Semantic proximity Read ↗

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.Semantic proximity Read ↗

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.Semantic proximity Read ↗

Hereditary ovarian cancer in Ashkenazi Jews.Semantic proximity Read ↗

Cancer incidence in a population of Jewish women at risk of ovarian cancer.Semantic proximity Read ↗

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.Semantic proximity Read ↗

Hereditary breast cancer in Jews.Semantic proximity Read ↗

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.